drugset / Trial / NCT04928300

Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs

NCT04928300

Phase 3 Recruiting 60 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.

Timeline

Start
2021-06-12
Primary completion
2027-07-01
Completion
2027-07-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg Intravenous

Indications

No indication recorded.